OrbusNeich Medical Group Holdings (FRA:Q8T) Other Operating Expense: €-0.6 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:Q8T OrbusNeich Medical Group Holdings Ltd FRA:Q8T
95 GF Score
Price €0.37
GF Value €0.48
! 2 Warning Signs
View Full Analysis

What is OrbusNeich Medical Group Holdings Other Operating Expense?

OrbusNeich Medical Group Holdings FRA:Q8T +5.06% 95 Other Operating Expense is €-0.6 Mil as of Dec. 2025. GuruFocus rates FRA:Q8T with a GF Score™ of 95/100 and a GF Value™ of €0.48. The stock has 2 warning signs investors should review.

OrbusNeich Medical Group Holdings's Other Operating Expense for the six months ended in Dec. 2025 was €-0.4 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.6 Mil.

OrbusNeich Medical Group Holdings's quarterly Other Operating Expense increased from Dec. 2024 (€-0.2 Mil) to Jun. 2025 (€-0.1 Mil) but then declined from Jun. 2025 (€-0.1 Mil) to Dec. 2025 (€-0.4 Mil).

OrbusNeich Medical Group Holdings's annual Other Operating Expense increased from Dec. 2023 (€-1.9 Mil) to Dec. 2024 (€-0.4 Mil) but then declined from Dec. 2024 (€-0.4 Mil) to Dec. 2025 (€-0.5 Mil).

OrbusNeich Medical Group Holdings Other Operating Expense Related Terms

OrbusNeich Medical Group Holdings Other Operating Expense Historical Data

* Premium members only.

The historical data trend for OrbusNeich Medical Group Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrbusNeich Medical Group Holdings Other Operating Expense Chart

OrbusNeich Medical Group Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial -1.23 -0.87 -1.95 -0.41 -0.54

OrbusNeich Medical Group Holdings Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.16 -0.25 -0.10 -0.44 -0.13
FRA:Q8T
95GF Score
OrbusNeich Medical Group Holdings Ltd FRA:Q8T
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrbusNeich Medical Group Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of €-0.6 Mil mean?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a Other Operating Expense of €-0.6 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on OrbusNeich Medical Group Holdings and its competitors.
Is OrbusNeich Medical Group Holdings' Other Operating Expense too high?
OrbusNeich Medical Group Holdings' current Other Operating Expense is €-0.6 Mil. Overall, OrbusNeich Medical Group Holdings has a GF Score™ of 95/100, reflecting its overall financial health beyond just this single metric.
How does OrbusNeich Medical Group Holdings' Other Operating Expense compare to ISRG and BDX?
OrbusNeich Medical Group Holdings' Other Operating Expense of €-0.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Medical Devices & Instruments company?
A good Other Operating Expense depends on the Medical Devices & Instruments industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on OrbusNeich Medical Group Holdings and its competitors. OrbusNeich Medical Group Holdings's current Other Operating Expense is €-0.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OrbusNeich Medical Group Holdings stock overvalued right now?
OrbusNeich Medical Group Holdings (FRA:Q8T) has a current Other Operating Expense of €-0.6 Mil. The stock's GF Value™ is €0.48, compared to a current price of €0.37 — trading 22.1% below its estimated fair value. The current Other Operating Expense is €-0.6 Mil. OrbusNeich Medical Group Holdings' overall GF Score™ is 95/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For OrbusNeich Medical Group Holdings (FRA:Q8T), the current Other Operating Expense is €-0.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OrbusNeich Medical Group Holdings (FRA:Q8T) Overvalued in 2026?

Based on GuruFocus' analysis, OrbusNeich Medical Group Holdings stock appears to be undervalued. The current stock price of €0.37 is trading 22.1% below its estimated GF Value™ of €0.48.

Key valuation signals for FRA:Q8T:

  • Other Operating Expense: €-0.6 Mil
  • GF Value™: €0.48 vs. price of €0.37 (22.1% below fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the FRA:Q8T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OrbusNeich Medical Group Holdings Business Description

Other Exchanges 06929:Hong Kong
Address 3rd Floor, Building 20E, Units 303 and 305, Hong Kong Science Park, Shatin New Town, Hong Kong, HKG
OrbusNeich Medical Group Holdings Ltd is an investment holding company. The Company principally engaged in the manufacturing, trading, sales and marketing of medical devices/instruments used for the treatment of coronary and peripheral vascular diseases. The group has only one operating segment. The company has presence in APAC, EMEA, Japan, United States, The PRC, and Others of which majority of revenue comes from APAC.
95GF Score

Get the complete analysis for FRA:Q8T

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.37
Price
€0.48
GF Value